Code Pharma, a Dutch pharmaceutical company, will showcase its innovative HIV drug, GAMMORA, at two global conferences in late 2024. First, in November at the HIV Drug Therapy Conference in Glasgow, early clinical trial results will be presented, followed by a December presentation at the HIV Persistence During Therapy Workshop in Miami.
GAMMORA represents a breakthrough by eliminating HIV-infected cells, unlike traditional treatments that only control the virus. Initial trials show it significantly reduces the viral load without side effects, offering hope for a potential cure. Code Pharma continues to drive innovation in peptide-based treatments.